Trial intelligence / Profile preview

Mycophenolate Mofetil for Neuromyelitis Optica in Japanese Patients

jRCTs051180080Completed

Start
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of mycophenolate mofetil in Neuromyelitis Optica Spectrum Disorder (NMOSD). Started Dec 2018; status: completed.

02

Drugs

mycophenolate mofetil
03

Conditions

Neuromyelitis Optica Spectrum Disorder (NMOSD)

Beyond the preview

Go deeper on jRCTs051180080.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs051180080.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call